Monday, April 13

3 European Stocks That May Be Undervalued In April 2026


As European markets experience a rally, buoyed by the U.S.-Iran ceasefire and resulting boost in investor sentiment, attention turns to potential opportunities within this optimistic environment. Identifying undervalued stocks during such periods can be beneficial, as these stocks may offer value through strong fundamentals that are not yet fully reflected in their current market prices.

Name

Current Price

Fair Value (Est)

Discount (Est)

Teleste Oyj (HLSE:TLT1V)

€3.50

€6.96

49.7%

SP Group (CPSE:SPG)

DKK386.00

DKK764.12

49.5%

Qrf Comm. VA (ENXTBR:QRF)

€11.10

€22.13

49.8%

Multiconsult (OB:MULTI)

NOK164.60

NOK326.08

49.5%

Mare Group (BIT:MARE)

€3.40

€6.73

49.5%

Maps (BIT:MAPS)

€2.46

€4.91

49.9%

Gabriel Holding (CPSE:GABR)

DKK228.00

DKK453.95

49.8%

Continental (XTRA:CON)

€65.16

€128.87

49.4%

B&S Group (ENXTAM:BSGR)

€5.85

€11.66

49.8%

Airbus (ENXTPA:AIR)

€169.50

€336.10

49.6%

Click here to see the full list of 182 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let’s dive into some prime choices out of the screener.

Overview: Ratos AB (publ) is a private equity firm that focuses on buyouts, turnarounds, add-on acquisitions, and middle market transactions, with a market cap of SEK11.29 billion.

Operations: The company’s revenue is segmented into Consumer (SEK4.53 billion), Product Solutions (SEK5.31 billion), Industrial Services (SEK5.12 billion), and Construction & Services (SEK3.93 billion).

Estimated Discount To Fair Value: 24.8%

Ratos AB is trading at SEK 34.22, significantly below its estimated future cash flow value of SEK 45.49, indicating it is undervalued by over 20%. Despite a challenging year with a net loss of SEK 1,743 million in Q4 2025, Ratos’s revenue growth is expected to outpace the Swedish market at an annual rate of 2.5%. However, its dividend yield of 4.09% isn’t well-supported by earnings, and return on equity remains modest at a forecasted 8.2%.

OM:RATO B Discounted Cash Flow as at Apr 2026
OM:RATO B Discounted Cash Flow as at Apr 2026

Overview: Vitrolife AB (publ) is a company that offers assisted reproduction products across Europe, the Middle East, Africa, Asia-Pacific, and the Americas with a market cap of SEK13.10 billion.

Operations: Vitrolife generates revenue from its assisted reproduction products across various regions including Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Estimated Discount To Fair Value: 48.8%

Vitrolife is trading at SEK 96.7, significantly below its estimated future cash flow value of SEK 188.69, suggesting undervaluation by over 20%. Despite a challenging fiscal year with a net loss of SEK 5.01 billion, earnings are forecast to grow substantially at over 100% annually as the company is expected to become profitable in three years. However, revenue growth remains moderate at an annual rate of 6%, slightly above the Swedish market average.

OM:VITR Discounted Cash Flow as at Apr 2026
OM:VITR Discounted Cash Flow as at Apr 2026

Overview: Zehnder Group AG, with a market cap of CHF780.29 million, develops, manufactures, and sells indoor climate systems across Europe, North America, and China.

Operations: The company’s revenue is derived from two segments: Radiators, contributing €259 million, and Ventilation, accounting for €501.70 million.

Estimated Discount To Fair Value: 41%

Zehnder Group, trading at CHF 70.2, is undervalued with a future cash flow value estimate of CHF 118.96, indicating it is more than 20% below its fair value. The company reported significant earnings growth to EUR 46.3 million from EUR 1.7 million last year and forecasts suggest continued profit growth at an annual rate of 14.4%, outpacing the Swiss market average. However, revenue growth remains moderate at a forecasted annual rate of 5.4%.

SWX:ZEHN Discounted Cash Flow as at Apr 2026
SWX:ZEHN Discounted Cash Flow as at Apr 2026

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OM:RATO B OM:VITR and SWX:ZEHN.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *